down arrow

Sequent Scien.

29
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE807F01027
  • NSEID: SEQUENT
  • BSEID: 512529
INR
136.75
4.65 (3.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.59 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
1,369.00
1,420.00
1,412.00
1,361.00
1,179.00
1,039.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,369.00
1,420.00
1,412.00
1,361.00
1,179.00
1,039.00
Expenditure (Ex Depriciation)
Stock Adjustments
-29.00
18.00
-49.00
-39.00
4.00
-27.00
Raw Materials Consumed
789.00
814.00
842.00
733.00
600.00
570.00
Power & Fuel Cost
35.00
42.00
33.00
28.00
24.00
23.00
Employee Cost
250.00
258.00
231.00
187.00
165.00
145.00
Operating Expenses
70.00
81.00
85.00
91.00
76.00
81.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
56.00
57.00
57.00
50.00
45.00
36.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
54.00
53.00
27.00
31.00
29.00
29.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,308.00
1,408.00
1,303.00
1,149.00
1,008.00
914.00
Operating Profit (PBDIT) excl Other Income
61.00
11.00
109.00
212.00
170.00
124.00
Other Income
10.00
6.00
10.00
8.00
10.00
8.00
Operating Profit (PBDIT)
72.00
18.00
120.00
220.00
180.00
133.00
Interest
48.00
35.00
15.00
24.00
35.00
32.00
Profit before Depriciation and Tax
24.00
-17.00
104.00
196.00
144.00
100.00
Depreciation
61.00
55.00
51.00
50.00
50.00
41.00
Profit Before Taxation & Exceptional Items
-37.00
-72.00
52.00
145.00
94.00
58.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-54.00
-137.00
52.00
136.00
94.00
58.00
Provision for Tax
-25.00
-15.00
8.00
32.00
12.00
2.00
Profit After Tax
-29.00
-121.00
44.00
104.00
82.00
56.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
99.00
88.00
59.00
-79.00
-140.00
-188.00
Profit Available for appropriations
63.00
-32.00
100.00
16.00
-70.00
-140.00
Appropriations
63.00
-32.00
100.00
16.00
-70.00
-140.00
Equity Dividend (%)
0.00%
0.00%
0.00%
25.00%
0.00%
10.00%
Earnings Per Share
-1.44
-4.88
1.66
3.87
2.87
2.00
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -3.60% vs 0.57% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 413.71% vs -89.07% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 35.39% vs 125.16% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 75.72% vs -372.49% in Mar 2023

Compare Profit and Loss Results of Sequent Scien.
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,369.00
10,334.00
-8,965.00
-86.75%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,369.00
10,334.00
-8,965.00
-86.75%
Expenditure (Ex Depriciation)
Stock Adjustments
-29.00
-94.00
65.00
69.15%
Raw Materials Consumed
789.00
3,263.00
-2,474.00
-75.82%
Power & Fuel Cost
35.00
129.00
-94.00
-72.87%
Employee Cost
250.00
2,274.00
-2,024.00
-89.01%
Operating Expenses
70.00
210.00
-140.00
-66.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
56.00
928.00
-872.00
-93.97%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
54.00
134.00
-80.00
-59.70%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,308.00
7,798.00
-6,490.00
-83.23%
Operating Profit (PBDIT) excl Other Income
61.00
2,536.00
-2,475.00
-97.59%
Other Income
10.00
280.00
-270.00
-96.43%
Operating Profit (PBDIT)
72.00
2,817.00
-2,745.00
-97.44%
Interest
48.00
35.00
13.00
37.14%
Profit before Depriciation and Tax
24.00
2,782.00
-2,758.00
-99.14%
Depreciation
61.00
398.00
-337.00
-84.67%
Profit Before Taxation & Exceptional Items
-37.00
2,384.00
-2,421.00
-101.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-54.00
2,399.00
-2,453.00
-102.25%
Provision for Tax
-25.00
457.00
-482.00
-105.47%
Profit After Tax
-29.00
1,926.00
-1,955.00
-101.51%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
99.00
8,012.00
-7,913.00
-98.76%
Profit Available for appropriations
63.00
9,925.00
-9,862.00
-99.37%
Appropriations
63.00
9,925.00
-9,862.00
-99.37%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-1.44
47.75
-49.19
-103.02%
Profit And Loss - Net Sales
Net Sales 1,369.73 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -3.60% vs 0.57% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 61.41 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 413.71% vs -89.07% in Mar 2023

Profit And Loss - Interest
Interest 48.09 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 35.39% vs 125.16% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax -29.61 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 75.72% vs -372.49% in Mar 2023